HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aesthetic Medicine

1,465.971

+25.2121.75%

Number of Gainers:4

Number of Losers:6

Number of Flat:3

PE:- -

High:1,473.594

Open:1,441.486

Low:1,412.502

Close:1,440.759

Volume:128.81M

Turnover:2.14B

Market Cap:240.51B

Float Cap:177.31B

Loading ...

CITIC Securities Maintains "Buy" Rating for CMS (00867), Citing Innovation-Driven Long-Term Growth Potential

Sihuan Pharmaceutical Receives Chinese Regulatory Nod for Human Studies of Diabetes Drug

MT Newswires Live

BRIEF-Sihuan Pharmaceutical Says P052 Injection Approved For Ind

Morgan Stanley Initiates Buy Rating on FOSUN PHARMA (02196) with A-Share Target Price of 42 RMB and H-Share Target Price of 33 HKD

SIHUAN PHARM (00460): Subsidiary Huisheng Bio Receives IND Approval for Self-Developed GLP-1R/GCGR Dual-Target Innovative Drug P052 Injection

Sihuan Pharmaceutical - P052 Injection Independently Developed by Huisheng Biopharmaceutical Approved for Ind

THOMSON REUTERS

BioNTech, Bristol Myers Say Read-Out Confirms Dose Selection for the Ongoing Pivotal Phase Iii Rosetta Lung-01 Trial

THOMSON REUTERS

BioNTech, Bristol Myers Squibb Say Bnt327 Plus Chemotherapy Shows Encouraging Antitumor Activity in Patients With Extensive-Stage Small Cell Lung Cancer

THOMSON REUTERS

BioNTech, Bristol Myers Say Interim Phase Ii Data Showed a 76.3% Confirmed Objective Response Rate, 100% Disease Control Rate

THOMSON REUTERS

Hong Kong Stock Market Analysis | Internal Restructuring Boosts Confidence as Giants Rally, Featured Stock SKYWORTH GROUP (00751) Surges at Market Close

Fosun Pharmaceutical Unit Gets China Nod for Lung Cancer Drug Trial

MT Newswires Live

Fosun Pharma's (600196.SH) Subsidiary Henlius Receives US FDA Approval for HLX17 Clinical Trial

AH Stock Statistics | September 8

China Merchants International: Chinese Pharmaceutical Stocks Expected to Continue Rising on Innovation Drug Overseas Expansion and Domestic Policy Optimization, Recommends Buying 3SBIO (01530) and Others

Why Sisram Medical Ltd (HKG:1696) Could Be Worth Watching

Simply Wall St.

Huatai Asset Management Increases Stake in 3SBIO (01530) by 2.092 Million Shares at HK$31.18 Per Share

AH Statistics | September 5

Hong Kong Stock Movement | Innovative Drug Stocks Rise Across the Board as 2025 World Lung Cancer Congress Approaches, Institutions Bullish on Valuation Recovery Potential of Innovative Drug Sector

SIHUAN PHARM (00460): Medical Aesthetics Surge and Innovation Drug Monetization Drive Valuation Recovery

BRIEF-Sisram Medical Co Announces Strategic Collaboration With Celebrity Skin Expert Nurse Jamie

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK1593/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":1465.9714,"timestamp":1757405290965,"preClose":1440.759,"halted":0,"volume":128805171,"delay":0,"changeRate":0.017499,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":25.212402,"latestTime":"09-09 16:00:00","open":1441.4856,"high":1473.5939,"low":1412.5018,"amount":2139217392,"amplitude":0.042403,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1757467800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1757381400000,1757390400000],[1757394000000,1757404800000]],"pbRate":2.085437,"peRate":29.311372,"turnoverRate":0.006228,"increases":4,"decrements":6,"flats":3,"marketCap":240505319816,"floatMarketCap":177312741768},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":1473.5939,"amplitude":0.042403,"preClose":1440.759,"low":1412.5018,"pbRate":"2.085437","latestPrice":1465.9714,"volume":128805171,"delay":0,"open":1441.4856,"prevYearClose":571.87146,"prevWeekClose":1420.862,"prevMonthClose":1253.623,"prevQuarterClose":1037.486,"fiveDayClose":1314.432,"twentyDayClose":1260.192,"sixtyDayClose":1033.634,"secType":"PLATE","market":"HK","turnoverRate":0.006228,"peRate":29.311372,"marketCap":240505319816,"floatMarketCap":177312741768,"timestamp":1757405290965,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":4,"down":6,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1174286274","title":"CITIC Securities Maintains \"Buy\" Rating for CMS (00867), Citing Innovation-Driven Long-Term Growth Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1174286274","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174286274?lang=en_us&edition=fundamental","pubTime":"2025-09-09 14:11","pubTimestamp":1757398283,"startTime":"0","endTime":"0","summary":"CITIC Securities issued a research report maintaining a \"Buy\" rating for CMS (00867), projecting revenues of RMB 8.31 billion, RMB 9.48 billion, and RMB 11.35 billion for 2025-2027, representing...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","IE00BGHQDM52.EUR","SG9999015986.USD","IE00BMCWC346.EUR","SG9999004220.SGD","IE00BVYPNP33.GBP","BK1593","BK1191","IE00BVYPNQ40.USD","IE00BYV24P56.USD","00867","SG9999015978.USD","SG9999015945.SGD","SG9999015952.SGD"],"gpt_icon":0},{"id":"2566652502","title":"Sihuan Pharmaceutical Receives Chinese Regulatory Nod for Human Studies of Diabetes Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2566652502","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566652502?lang=en_us&edition=fundamental","pubTime":"2025-09-09 10:31","pubTimestamp":1757385061,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical  said Chinese regulators approved its experimental P052 injection for human studies, according to a Hong Kong bourse filing Tuesday.The company is developing P052 as a treatment for type 2 diabetes and obesity.The drug has a mechanism similar to Novo Nordisk's semaglutide.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","BK1593","00460","BK1600","BK1191"],"gpt_icon":0},{"id":"2566965651","title":"BRIEF-Sihuan Pharmaceutical Says P052 Injection Approved For Ind","url":"https://stock-news.laohu8.com/highlight/detail?id=2566965651","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566965651?lang=en_us&edition=fundamental","pubTime":"2025-09-09 09:33","pubTimestamp":1757381597,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharmaceutical Says P052 Injection Approved For IndSept 9 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:P052 INJECTION INDEPENDENTLY DEVELOPED BY HUISHENG BIOPHARMACEUTICAL APPROVED FOR INDFurther company coverage: 0460.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nFWN3UV1CM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1600","00460","BK1191","BK1593"],"gpt_icon":0},{"id":"1153469279","title":"Morgan Stanley Initiates Buy Rating on FOSUN PHARMA (02196) with A-Share Target Price of 42 RMB and H-Share Target Price of 33 HKD","url":"https://stock-news.laohu8.com/highlight/detail?id=1153469279","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153469279?lang=en_us&edition=fundamental","pubTime":"2025-09-09 08:34","pubTimestamp":1757378072,"startTime":"0","endTime":"0","summary":"According to recent reports, international investment bank Morgan Stanley has released a latest research report stating that FOSUN PHARMA (600196.SH, 02196) is demonstrating improving profitability...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0096","BK0196","BK0012","BK0183","02196","BK0188","BK1191","600196","BK0175","BK0239","BK1515","159982","BK0187","BK0060","BK1593","399300","BK0028"],"gpt_icon":0},{"id":"1131898226","title":"SIHUAN PHARM (00460): Subsidiary Huisheng Bio Receives IND Approval for Self-Developed GLP-1R/GCGR Dual-Target Innovative Drug P052 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1131898226","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131898226?lang=en_us&edition=fundamental","pubTime":"2025-09-09 08:16","pubTimestamp":1757376982,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) announced that its non-wholly owned subsidiary, Huisheng Biopharmaceutical Co., Ltd. (Huisheng Bio), has received tacit approval from the Center for Drug Evaluation (CDE) of the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1191","06978","BK1574","BK1515","BK1593","BK4590","BK1600","GLP","159992","BK4144","00460"],"gpt_icon":0},{"id":"2566653655","title":"Sihuan Pharmaceutical - P052 Injection Independently Developed by Huisheng Biopharmaceutical Approved for Ind","url":"https://stock-news.laohu8.com/highlight/detail?id=2566653655","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566653655?lang=en_us&edition=fundamental","pubTime":"2025-09-09 08:02","pubTimestamp":1757376174,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nFWN3UV1CM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1593","BK1191","BK1515","00460","BK1600"],"gpt_icon":0},{"id":"2565868045","title":"BioNTech, Bristol Myers Say Read-Out Confirms Dose Selection for the Ongoing Pivotal Phase Iii Rosetta Lung-01 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2565868045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565868045?lang=en_us&edition=fundamental","pubTime":"2025-09-08 23:00","pubTimestamp":1757343600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nL6N3US0KM:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0114720955.EUR","IE00BSNM7G36.USD","LU1291159041.SGD","BK4139","SG9999001440.SGD","BNTX","LU1069347547.HKD","LU2106854487.HKD","LU0965509010.AUD","LU2242646821.SGD","LU1116320901.HKD","LU1934455277.USD","SG9999001176.USD","BK1593","LU2324357040.USD","BK4007","SG9999002224.SGD","LU0211331839.USD","SG9999002232.USD","LU0237698245.USD","01530","LU2361044949.HKD","LU0225284248.USD","IE00BBT3K403.USD","LU0985481810.HKD","MRK","IE00B4R5TH58.HKD","LU2133065610.SGD","LU1057294990.SGD","LU1868836591.USD","SG9999014542.SGD","BK4548","LU1989771016.USD","LU1571399168.USD","LU0122379950.USD","BK4535","LU1983299246.USD","BK4588","IE00BFTCPJ56.SGD","BK4568","LU1023059063.AUD","BK4550","LU1032466523.USD","LU1699723380.USD","LU2023250504.SGD","BK1161","BMY","LU1941712264.USD","LU1061106388.HKD","LU1868836914.USD"],"gpt_icon":0},{"id":"2565680426","title":"BioNTech, Bristol Myers Squibb Say Bnt327 Plus Chemotherapy Shows Encouraging Antitumor Activity in Patients With Extensive-Stage Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2565680426","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565680426?lang=en_us&edition=fundamental","pubTime":"2025-09-08 23:00","pubTimestamp":1757343600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nL6N3US0KM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2106854487.HKD","IE00BFTCPJ56.SGD","LU1032466523.USD","BK1593","LU1116320901.HKD","LU0114720955.EUR","BK4550","LU1057294990.SGD","LU1868836914.USD","LU1023059063.AUD","BNTX","LU0965509010.AUD","LU1069347547.HKD","LU1989771016.USD","LU0237698245.USD","SG9999001440.SGD","LU1571399168.USD","SG9999014542.SGD","IE00B4R5TH58.HKD","BK4139","LU1868836591.USD","01530","LU2242646821.SGD","IE00BBT3K403.USD","BK4548","LU2324357040.USD","SG9999002224.SGD","BK1161","LU2133065610.SGD","LU0211331839.USD","LU1061106388.HKD","LU1291159041.SGD","BK4568","LU1941712264.USD","LU0985481810.HKD","LU2023250504.SGD","LU0122379950.USD","LU2361044949.HKD","BK4007","SG9999001176.USD","LU1934455277.USD","LU1983299246.USD","BMY","MRK","BK4535","BK4588","LU0225284248.USD","SG9999002232.USD","IE00BSNM7G36.USD","LU1699723380.USD"],"gpt_icon":0},{"id":"2565451680","title":"BioNTech, Bristol Myers Say Interim Phase Ii Data Showed a 76.3% Confirmed Objective Response Rate, 100% Disease Control Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2565451680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565451680?lang=en_us&edition=fundamental","pubTime":"2025-09-08 23:00","pubTimestamp":1757343600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nL6N3US0KM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1868836914.USD","SG9999001440.SGD","LU2133065610.SGD","LU0237698245.USD","IE00BBT3K403.USD","LU0965509010.AUD","BK4548","BK4568","BK4550","01530","LU0114720955.EUR","LU1057294990.SGD","LU2361044949.HKD","SG9999014542.SGD","SG9999002232.USD","IE00BSNM7G36.USD","MRK","IE00B4R5TH58.HKD","LU1023059063.AUD","LU2106854487.HKD","BMY","LU1868836591.USD","LU2242646821.SGD","LU0985481810.HKD","BK4535","LU0122379950.USD","LU1571399168.USD","LU0225284248.USD","LU1934455277.USD","SG9999002224.SGD","LU2324357040.USD","BK4007","BNTX","LU1291159041.SGD","LU1699723380.USD","LU2023250504.SGD","LU1069347547.HKD","BK1593","LU0211331839.USD","LU1032466523.USD","LU1061106388.HKD","IE00BFTCPJ56.SGD","BK4588","LU1941712264.USD","SG9999001176.USD","BK1161","LU1983299246.USD","LU1989771016.USD","LU1116320901.HKD","BK4139"],"gpt_icon":0},{"id":"1153747757","title":"Hong Kong Stock Market Analysis | Internal Restructuring Boosts Confidence as Giants Rally, Featured Stock SKYWORTH GROUP (00751) Surges at Market Close","url":"https://stock-news.laohu8.com/highlight/detail?id=1153747757","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153747757?lang=en_us&edition=fundamental","pubTime":"2025-09-08 20:09","pubTimestamp":1757333347,"startTime":"0","endTime":"0","summary":"**Market Overview** Following last week's intense short-selling pressure, bullish forces began to emerge after withstanding the downturn. Both mainland and Hong Kong markets rebounded positively...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823040885.USD","00867","00902","BK1191","BK4614","LU0054450605.USD","LU0214875030.USD","YANG","LU0449515922.USD","HSTECH","HK0000252152.HKD","BK1570","SG9999004220.SGD","01811","HSCEI","IE00BMCWC346.EUR","BK1125","BK1558","00836","LU0254981946.USD","IE00BVYPNP33.GBP","SG9999015986.USD","SG9999015978.USD","IE00BYV24P56.USD","IE00BGHQDM52.EUR","HK0000252160.HKD","BK1096","IE00BVYPNQ40.USD","LU2488822045.USD","SG9999015945.SGD","BK1557","HK0000500386.USD","BK1594","BK1524","02380","00751","00916","BK1154","BK1593","LU0531970944.HKD","SG9999015952.SGD","LU0449509016.USD","BK1530","07226"],"gpt_icon":1},{"id":"2565689357","title":"Fosun Pharmaceutical Unit Gets China Nod for Lung Cancer Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2565689357","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565689357?lang=en_us&edition=fundamental","pubTime":"2025-09-08 19:58","pubTimestamp":1757332735,"startTime":"0","endTime":"0","summary":"A unit of Shanghai Fosun Pharmaceutical  unit obtained approval from China's National Medical Products Administration for the clinical trial of Foritinib Succinate Capsules, a Monday Hong Kong bourse filing said.The trial will study the drug for adjuvant treatment following the radical resection of tumor in patients with stage IB to IIIA non-small cell lung cancer.Unit Fosun Wanbang  Pharmaceutical Group will begin the phase III trial of the drug once the relevant conditions are met.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","BK0060","BK0196","BK0175","BK0096","BK0187","BK1515","BK1191","BK0188","BK1593","00656","BK0012","BK0183","600196","BK0028","02196"],"gpt_icon":0},{"id":"1174416304","title":"Fosun Pharma's (600196.SH) Subsidiary Henlius Receives US FDA Approval for HLX17 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1174416304","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174416304?lang=en_us&edition=fundamental","pubTime":"2025-09-08 18:16","pubTimestamp":1757326598,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. (600196.SH) announced that its controlled subsidiary Shanghai Henlius Biotech, Inc. and its controlled subsidiaries (collectively \"Henlius\") recently...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","BK0096","BK0188","BK0187","BK0028","BK1161","BK1515","BK0060","BK0175","BK1593","BK0239","BK1191","BK0196","BK0012","02196","600196","BK0183"],"gpt_icon":0},{"id":"1148042170","title":"AH Stock Statistics | September 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1148042170","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148042170?lang=en_us&edition=fundamental","pubTime":"2025-09-08 16:16","pubTimestamp":1757319405,"startTime":"0","endTime":"0","summary":"As of the close on September 8, NE ELECTRIC (00042), HOLLY FUTURES (03678), and FUDANZHANGJIANG (01349) ranked as the top three AH stocks by premium rate, with premiums of 785.25%, 238.95%, and...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0051755006.USD","LU0106252389.USD","BK1174","BK1130","BK1610","IE00B031J352.USD","LU0049853897.USD","LU1813983027.USD","LU1152091754.HKD","IE00BZ08YS42.EUR","LU0588545904.SGD","BK1105","LU0289961442.SGD","GWLLY","00038","HK0000306685.HKD","BYDDY","LU0327786744.USD","BK1183","LU0214875030.USD","00187","BK1140","BK1149","LU1868837722.USD","LU0320764599.SGD","LU0828237940.HKD","BK1551","00719","LU1211504680.USD","LU2357125470.USD","LU2097828474.EUR","02603","IE00BGHQDM52.EUR","IE00BYV24P56.USD","BK1564","LU0315179316.USD","LU0531970944.HKD","LU0516422366.SGD","LU0594300179.USD","BK1123","BK1539","BK1144","LU0531971595.HKD","LU0588546209.SGD","LU0823414551.USD","LU0880133367.SGD","BK1206","LU1023057109.AUD","LU0828237510.HKD","LU1048596156.SGD","BK1191","BK1506","BK1236","LU1152091168.USD","01108","LU1242518931.SGD","BK1119","LU0052750758.USD","LU0181495838.USD","BK1523","LU0370786039.SGD","LU1688375341.USD","00358","002594","LU2148510915.USD","399300","LU0345780521.USD","LU2476274720.SGD","SG9999015952.SGD","LU0431992006.USD","00811","HK0000320264.USD","LU1880383440.USD","LU0175139822.USD","HK0000252152.HKD","LU1282649141.HKD","LU0244354667.USD","BK1141","02465","01276","BK1125","LU0865486749.SGD","LU2506951792.HKD","LU1719994722.HKD","LU2360107325.USD","LU0650527681.SGD","LU0173614495.USD","LU0254981946.USD","LU0228367735.SGD","IE00B5MMRT66.SGD","BK1582","BK1522","LU0509642566.USD","LU0572944931.SGD","LU0819121731.USD","LU0417516738.SGD","02039","LU0289739343.SGD","SG9999006514.SGD","IE00BD6J9T35.USD","BK1137","BK1565","LU1831875114.USD","LU0359202008.SGD","LU0886674414.USD","LU0819123356.HKD","00300","IE0034224299.USD","00317","BK1154","LU2348774022.SGD","LU0501845795.SGD","SG9999001226.SGD","LU0061477393.USD","LU0449515922.USD","LU1008478684.HKD","LU0516423091.SGD","LU0823040885.USD","LU2153592121.USD","LU0348825331.USD","02196","SG9999015986.USD","BK1198","LU2097828805.USD","LU0096374516.USD","LU0211977185.USD","LU1366334651.USD","BK1223","LU0828238088.HKD","LU1251922891.USD","BK1562","BK1554","00042","01349","LU0588545730.USD","LU2543165471.USD","LU0348827113.USD","LU0823038988.USD","LU1115378108.SGD","HYDD.SI","LU0979878070.USD","03678","LU0326950275.SGD","BK1568","LU0231483743.USD","LU0405327494.USD","02727","601633","BK1237","82333","BK1543","BK1593","LU0823426308.USD","LU1046422090.SGD","LU1366334578.USD","LU1861219969.SGD","BK1574","LU1960683339.HKD","LU2097828631.EUR","LU0588545490.SGD","LU0307460666.USD","IE00BVYPNQ40.USD","03750","BK1558","LU1675838814.USD","LU0469268626.HKD","IE00BZ08YT58.USD","SG9999002828.SGD","LU0039217434.USD","LU0228659784.USD","BK1560","BK1515","LU0164872284.USD","BK1505","LU0593848301.USD","LU0348814723.USD","LU0821914370.USD","LU0359201885.HKD","06869","LU1861214812.USD","LU2097828557.USD","BK1592","LU0918141705.HKD","LU0345780281.USD","LU1655091616.SGD","IE00B3M56506.USD","BK1521","LU0455707207.USD","BK1148","LU0540923850.HKD","BK1567","LU1961090484.USD","LU0561508036.HKD","BK1110","01211","LU1224709979.USD","LU1868838027.USD","HK0000306701.USD","BK1546","LU0890818403.SGD","IE00BVYPNP33.GBP","LU1242518857.USD","LU2039709279.SGD","LU2294711713.HKD","LU0634319403.HKD","LU0868486357.SGD","LU1770034418.SGD","LU0791591158.USD","LU0502904849.HKD","LU0505663152.USD","LU2097828714.EUR","IE00BZ08YR35.GBP","LU1064131003.USD","BK1509","SG9999006597.SGD","LU0359201612.USD","LU0163747925.USD","LU0449509016.USD","BK1214","LU0456846285.SGD","LU1105468828.SGD","BK1181","SG9999015978.USD","LU0456827905.SGD","LU0823426480.USD","HK0000252160.HKD","IE00BMCWC346.EUR","LU0708995583.HKD","IE00B031HY20.USD","06127","LU0048580855.USD","LU1282649067.USD","SG9999014674.SGD","LU1794554557.SGD","LU0348788117.USD","LU0511384066.AUD","LU0640798160.USD","LU0823414478.USD","01812","LU0072913022.USD","BK1561","02333","LU0143863784.USD","LU0054450605.USD","06185","BK1231","LU1808992512.USD","LU0594300419.USD","LU2226246903.HKD","LU0417516902.SGD","LU0348735423.USD","03606","LU1504937902.USD","LU1720050803.USD","LU0140636845.USD","BK1544","BK1507","81211","LU1282649810.SGD","LU0384037296.USD","00895","IE00B0169L03.USD","HK0000320223.HKD","BK1540","IE0008369823.USD","LU1993786604.SGD","LU0287142896.SGD","IE00BF5LJ272.USD","LU0259732245.USD","LU1188198961.HKD","LU0084288322.USD","LU0289960550.SGD","LU2125910500.SGD","IE0008368742.USD","LU0229945570.USD","LU0117841782.USD","LU0589944569.HKD","LU0348816934.USD","LU0918141887.USD","BK1514","IE00B29SXG58.USD","LU0543330566.HKD","03143","LU1868837565.USD","LU2242644610.SGD","LU0516423174.USD","SG9999003461.SGD","HK0000500386.USD","BK1116","01057","BK1171","LU0314109678.HKD","LU2778985437.USD","LU0791590937.USD","LU0348805143.USD","LU0463099449.HKD","01033","LU1880383366.USD","06693","IE0031814852.USD","LU0797268264.HKD","159982","BK1552","00753","LU0067412154.USD","LU0856984785.SGD","LU1064130708.USD","LU2476274308.USD","02359","BK1205","00525","BK1513","LU0605514214.HKD","02899","LU0269904917.USD","LU2249611893.SGD","LU0488056044.USD","LU0315178854.USD","BK1161","LU0737861699.HKD","LU0043850808.USD","LU0871576103.HKD","BK1594","LU0143863198.USD","LU0648948544.HKD","03968","BK1202","LU0823039010.USD","SG9999004220.SGD","LU0405327148.USD","LU0516422952.EUR","LU1807302812.USD","SG9999002463.SGD","BK1147","LU1282648689.USD","LU0106959298.USD","LU0516422440.USD","01800","LU1303224171.USD","02218","LU0862451753.SGD","LU2045819591.USD","BK1576","00991","BK1583","BK1537","LU2399975544.HKD","LU1328277881.USD","SG9999015945.SGD","00916","LU0165289439.USD","BK1530","LU0164865239.USD","IE00B543WZ88.USD","LU1226287529.USD","LU2449936058.SGD"],"gpt_icon":1},{"id":"1152030014","title":"China Merchants International: Chinese Pharmaceutical Stocks Expected to Continue Rising on Innovation Drug Overseas Expansion and Domestic Policy Optimization, Recommends Buying 3SBIO (01530) and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=1152030014","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152030014?lang=en_us&edition=fundamental","pubTime":"2025-09-08 14:36","pubTimestamp":1757313378,"startTime":"0","endTime":"0","summary":"China Merchants International released a research report stating that the Chinese pharmaceutical industry is expected to continue its upward trajectory, benefiting from positive factors including...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004311.SGD","BK1583","06978","159992","BK1191","IE00BZ08YT58.USD","BK1161","01177","BK1515","BK1521","01801","LU2328871848.SGD","BK1589","IE00BZ08YS42.EUR","SG9999014674.SGD","LU2097828714.EUR","02273","LU0502904849.HKD","LU2097828805.USD","02367","02268","LU2097828474.EUR","LU0455707207.USD","BK1141","BK1574","LU2097828557.USD","LU2488822045.USD","BK0188","LU1969619763.USD","BK0010","BK0175","LU2097828631.EUR","BK0185","IE00BZ08YR35.GBP","BK1593","600056","BK0250","BK0082","BK1207","BK0028","LU2242644610.SGD","BK1219","01530"],"gpt_icon":1},{"id":"2565959494","title":"Why Sisram Medical Ltd (HKG:1696) Could Be Worth Watching","url":"https://stock-news.laohu8.com/highlight/detail?id=2565959494","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565959494?lang=en_us&edition=fundamental","pubTime":"2025-09-06 06:16","pubTimestamp":1757110592,"startTime":"0","endTime":"0","summary":"While Sisram Medical Ltd ( HKG:1696 ) might not have the largest market cap around , it received a lot of attention...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1696/sisram-medical-shares/news/why-sisram-medical-ltd-hkg1696-could-be-worth-watching","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1696/sisram-medical-shares/news/why-sisram-medical-ltd-hkg1696-could-be-worth-watching","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1585","BK1593","BK1100","01696"],"gpt_icon":0},{"id":"1158278791","title":"Huatai Asset Management Increases Stake in 3SBIO (01530) by 2.092 Million Shares at HK$31.18 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1158278791","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158278791?lang=en_us&edition=fundamental","pubTime":"2025-09-05 19:14","pubTimestamp":1757070852,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on September 2nd, Huatai Asset Management Co., Ltd. increased its holdings in 3SBIO (01530) by 2.092 million shares at HK$31.18 per...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","BK1593","01530"],"gpt_icon":1},{"id":"1129940679","title":"AH Statistics | September 5","url":"https://stock-news.laohu8.com/highlight/detail?id=1129940679","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129940679?lang=en_us&edition=fundamental","pubTime":"2025-09-05 16:18","pubTimestamp":1757060328,"startTime":"0","endTime":"0","summary":"As of the close on September 5, NE ELECTRIC (00042), HOLLY FUTURES (03678), and ANDRE JUICE (02218) ranked as the top three in AH premium rates, with premium rates of 831.03%, 231.50%, and 231.11%...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861219969.SGD","LU1023057109.AUD","LU1282649067.USD","LU2506951792.HKD","LU2045819591.USD","LU0117841782.USD","BK1564","BK1105","LU2148510915.USD","LU0106252389.USD","LU0043850808.USD","02333","BK1521","LU0819123356.HKD","LU2242644610.SGD","LU2153592121.USD","LU1868838027.USD","LU0054450605.USD","LU0791590937.USD","LU0314109678.HKD","LU2097828474.EUR","SG9999015978.USD","SG9999002463.SGD","02899","BK1171","LU0359202008.SGD","SG9999014674.SGD","LU0067412154.USD","LU0797268264.HKD","LU1861214812.USD","LU1242518857.USD","LU0049853897.USD","LU1880383366.USD","01349","IE00B031J352.USD","IE00BZ08YR35.GBP","BK1202","BK1551","LU1688375341.USD","LU0708995583.HKD","SGXZ49509284.SGD","LU0543330566.HKD","01057","LU0531970944.HKD","LU0871576103.HKD","LU0540923850.HKD","LU0791591158.USD","01812","HK0000252160.HKD","LU0823426480.USD","LU0886674414.USD","159982","LU2125910500.SGD","IE00BVYPNP33.GBP","LU1064131003.USD","LU0287142896.SGD","LU0164865239.USD","BK1206","IE00B031HY20.USD","00991","02039","LU0511384066.AUD","BK1237","LU0640798160.USD","LU0868486357.SGD","01211","LU0315178854.USD","BK1565","SG9999015952.SGD","BK1530","LU0348825331.USD","LU0359201885.HKD","SG9999001226.SGD","LU0516423174.USD","BK1141","LU2476274720.SGD","BK1116","SG9999006514.SGD","LU0315179316.USD","LU0229945570.USD","LU2097828631.EUR","LU0449515922.USD","BK1535","HK0000500386.USD","IE00B3M56506.USD","LU0531971595.HKD","IE0034224299.USD","LU2249611893.SGD","HK0000306701.USD","LU0572944931.SGD","LU0244354667.USD","02338","LU0307460666.USD","LU0348735423.USD","LU0823038988.USD","LU0469268626.HKD","SG9999006597.SGD","LU0173614495.USD","06127","BK1582","LU0348814723.USD","IE0008368742.USD","LU0405327494.USD","LU0823039010.USD","SG9999015945.SGD","SG9999015986.USD","HK0000252152.HKD","HK0000320264.USD","LU0211977185.USD","LU1807302812.USD","LU1303224171.USD","00916","BK1198","06869","LU0823414478.USD","BK1140","LU1504937902.USD","BK1125","LU0163747925.USD","LU0259732245.USD","IE00B5MMRT66.SGD","LU2348774022.SGD","LU1211504680.USD","BK1110","BK1166","LU1655091616.SGD","LU0918141887.USD","GWLLY","LU0417516902.SGD","LU0345780521.USD","002594","LU0164872284.USD","LU0516422366.SGD","LU1794554557.SGD","LU0051755006.USD","00525","IE0008369823.USD","LU0594300419.USD","SGXZ81163826.USD","601633","03143","IE00BMCWC346.EUR","LU1961090484.USD","LU0880133367.SGD","LU1328277881.USD","LU0737861699.HKD","LU0348816934.USD","LU1868837565.USD","LU0648948544.HKD","LU0096374516.USD","BK1594","BK1560","BK1205","LU2039709279.SGD","00895","LU0634319403.HKD","LU0449509016.USD","LU1251922891.USD","BK1567","03606","LU0456827905.SGD","LU2097828557.USD","BK1558","IE0031814852.USD","LU0594300179.USD","BK1513","LU0823414551.USD","LU0593848301.USD","01108","BK1592","LU0289961442.SGD","LU1720050803.USD","LU0072913022.USD","BK1540","LU1675838814.USD","LU0589944569.HKD","LU0501845795.SGD","LU0588546209.SGD","LU0821914370.USD","02603","LU1770034418.SGD","LU0231483743.USD","BK1546","LU2543165471.USD","LU0345780281.USD","LU2476274308.USD","BK1214","LU0823040885.USD","LU2357125470.USD","IE00BD6J9T35.USD","BK1576","BK1552","LU0384037296.USD","BK1509","BK1149","BK1537","HK0000320223.HKD","LU0143863784.USD","LU1224709979.USD","LU0650527681.SGD","LU1868837722.USD","IE00B0169L03.USD","LU0181495838.USD","BK1144","02465","82333","00981","IE00B29SXG58.USD","LU1282648689.USD","HYDD.SI","399300","LU0979878070.USD","81211","BK1568","02218","IE00B543WZ88.USD","LU0143863198.USD","LU0455707207.USD","LU0856984785.SGD","LU0862451753.SGD","LU0502904849.HKD","06185","BK0214","LU1188198961.HKD","LU0463099449.HKD","BK1148","LU1242518931.SGD","LU1064130708.USD","00300","LU0456846285.SGD","LU0605514214.HKD","BK1523","LU0254981946.USD","LU1813983027.USD","BK1231","LU0359201612.USD","BK1539","LU0327786744.USD","LU0865486749.SGD","HK0000306685.HKD","LU1993786604.SGD","688981","LU1282649810.SGD","LU1152091168.USD","00187","LU1048596156.SGD","BK1583","LU2449936058.SGD","IE00BVYPNQ40.USD","BK1223","LU0823426308.USD","LU0289739343.SGD","BK1526","LU0214875030.USD","LU0890818403.SGD","LU1366334651.USD","LU0918141705.HKD","LU2294711713.HKD","BK1506","LU0370786039.SGD","LU0175139822.USD","LU0828238088.HKD","BK1610","LU0348827113.USD","02359","LU1366334578.USD","LU2399975544.HKD","BK1183","LU0431992006.USD","LU1115378108.SGD","LU0516422440.USD","BK1522","LU2097828714.EUR","BK1614","LU0488056044.USD","IE00BZ08YS42.EUR","LU0588545730.USD","BK1191","LU0561508036.HKD","LU0417516738.SGD","IE00BGHQDM52.EUR","LU1719994722.HKD","01138","LU1831875114.USD","LU0828237510.HKD","LU1152091754.HKD","02208","LU1226287529.USD","BYDDY","LU0228659784.USD","LU0106959298.USD","IE00BF5LJ272.USD","BK1137","LU0326950275.SGD","LU0061477393.USD","00358","IE00BZ08YT58.USD","BK1161","BK1514","BK1607","03968","BK1593","LU1880383440.USD","03750","LU0509642566.USD","LU0165289439.USD","IE00BYV24P56.USD","SG9999002828.SGD","LU0039217434.USD","LU0828237940.HKD","LU0516422952.EUR","LU1046422090.SGD","LU0228367735.SGD","01800","LU0084288322.USD","BK1562","09989","LU2360107325.USD","LU2226246903.HKD","LU2097828805.USD","BK1119","LU0516423091.SGD","LU0505663152.USD","LU0348805143.USD","LU1960683339.HKD","LU0269904917.USD","LU0819121731.USD","LU2778985437.USD","LU0588545904.SGD","SG9999003461.SGD","01276","LU0405327148.USD","LU0048580855.USD","LU0052750758.USD","BK1507","BK1505","02196","LU0348788117.USD","BK1544","BK1154","SG9999004220.SGD","BK1554","BK1147","01033","LU0289960550.SGD","00042","LU1282649141.HKD","03678","LU0140636845.USD","LU1808992512.USD","BK1515","LU1008478684.HKD","LU0320764599.SGD","LU0588545490.SGD","BK1236","LU1105468828.SGD","BK1163","BK1574"],"gpt_icon":1},{"id":"1169680585","title":"Hong Kong Stock Movement | Innovative Drug Stocks Rise Across the Board as 2025 World Lung Cancer Congress Approaches, Institutions Bullish on Valuation Recovery Potential of Innovative Drug Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1169680585","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169680585?lang=en_us&edition=fundamental","pubTime":"2025-09-05 11:20","pubTimestamp":1757042430,"startTime":"0","endTime":"0","summary":"Innovative drug stocks surged across the board. As of press time, 3SBIO (01530) rose 9.55% to HK$33.04; HBM HOLDINGS-B (02142) gained 6.25% to HK$16.99; HUTCHMED (00013) climbed 5.81% to HK$24.76;...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002562.SGD","SG9999002463.SGD","LU0359202008.SGD","LU0052750758.USD","06978","LU0856984785.SGD","LU0516422440.USD","LU2543165471.USD","LU0516422952.EUR","LU0572944931.SGD","BK1161","BK1593","00013","LU0051755006.USD","02269","LU0140636845.USD","LU1880383366.USD","BK1583","BK1587","LU1023057109.AUD","LU1242518931.SGD","LU0039217434.USD","LU0823426308.USD","02142","BK1576","LU0417516902.SGD","LU1688375341.USD","LU2039709279.SGD","LU0320764599.SGD","IE00B0JY6N72.USD","BK1610","LU0359201885.HKD","LU0819121731.USD","LU1794554557.SGD","03933","159992","BK1574","LU0708995583.HKD","BK1191","LU0516422366.SGD","LU0326950275.SGD","LU0516423091.SGD","BK1589","LU0348825331.USD","LU0348735423.USD","LU0456827905.SGD","LU0456846285.SGD","01276","01530","LU0327786744.USD","LU0359201612.USD","LU0043850808.USD","LU0417516738.SGD","BK1141","LU0823426480.USD","LU1720050803.USD","LU0307460666.USD","LU0516423174.USD","BK1521","LU0979878070.USD","LU0588546209.SGD","BK1588","LU1242518857.USD","LU0181495838.USD"],"gpt_icon":1},{"id":"1124538763","title":"SIHUAN PHARM (00460): Medical Aesthetics Surge and Innovation Drug Monetization Drive Valuation Recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=1124538763","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124538763?lang=en_us&edition=fundamental","pubTime":"2025-09-05 09:03","pubTimestamp":1757034204,"startTime":"0","endTime":"0","summary":"Southbound capital continues its robust influx into Hong Kong stocks, establishing the market as Asia's capital reservoir. According to Wind data, as of September 3, 2025, southbound funds through...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1600","BK1574","159992","BK1191","BK1161","BK1593","00460","BK1515"],"gpt_icon":0},{"id":"2564306371","title":"BRIEF-Sisram Medical Co Announces Strategic Collaboration With Celebrity Skin Expert Nurse Jamie","url":"https://stock-news.laohu8.com/highlight/detail?id=2564306371","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564306371?lang=en_us&edition=fundamental","pubTime":"2025-09-04 23:56","pubTimestamp":1757001360,"startTime":"0","endTime":"0","summary":"BRIEF-Sisram Medical Co Announces Strategic Collaboration With Celebrity Skin Expert Nurse JamieSept 4  - Sisram Medical Ltd 1696.HK:ALMA, A SISRAM MEDICAL COMPANY, ANNOUNCES STRATEGIC COLLABORATION WITH CELEBRITY SKIN EXPERT NURSE JAMIE TO EXPAND GLOBAL CONSUMER PRESENCE ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nTUA6VPMXS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","01696","BK1585","BK1593"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":91,"code":"91000000","status":"200"}]}}